ABOUT
CELLTELLIGENCE

Celltelligence is a unique mix of industry experts, analysts, and academics dedicated to bringing deeper context and insight to the cell therapy market. Here’s why we’re different.

ABOUT
CELLTELLIGENCE

Celltelligence is a unique mix of industry experts, analysts, and academics dedicated to bringing deeper context and insight to the cell therapy market. Here’s why were different.

WHO WE ARE

Our team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.

WHO WE ARE

Our team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.

WHY WE’RE DIFFERENT

Celltelligence isn’t just another newsletter or curated content blast. Our market intelligence is heavily researched, up-to-date, and deeply informed by our direct relationships with cell therapy stakeholders including KOLs. This provides our customers with an insider’s perspective on the market, helping you to create more accurate forecasts and quicker calculated decisions.

WHY WE’RE DIFFERENT

Celltelligence isn’t just another newsletter or curated content blast. Our market intelligence is heavily researched, up-to-date, and deeply informed by our direct relationships with cell therapy stakeholders including KOLs. This provides our customers with an insider’s perspective on the market, helping you to create more accurate forecasts and quicker calculated decisions.

HOW WE MAKE YOUR JOB EASIER

The Blast, Map, and Library are all designed for people who care about cell therapy and want better, easier options to leverage market insight. We tailor content to all relevant stakeholders – including industry professionals, academics, and both buy- and sell-side analysts. With Celltelligence, you’ll make it easier to uncover blindspots and stay on top of industry movement for your organization or your clients.

HOW WE MAKE YOUR JOB EASIER

The Blast, Map, and Library are all designed for people who care about cell therapy and want better, easier options to leverage market insight. We tailor content to all relevant stakeholders – including industry professionals, academics, and both buy- and sell-side analysts. With Celltelligence, you’ll make it easier to uncover blindspots and stay on top of industry movement for your organization or your clients.

MEET THE ‘TELLIGENCE IN OUR TEAM

Matthew Maryniak
Team Lead
  • Co-founder & President of Fenix Group International, LLC, a global life sciences consulting firm parent company of Celltelligence (2015-present)
  • Former Principal at IQVIA Consulting Group (8 years tenure)
  • Recognized industry expert in Pink Sheet, PM360, and journal article
  • MBA in Pharmaceutical Business, Univ of Sciences in PHL
Antonio Marti Polo, MSc
Senior Content Lead
  • Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2020-present)
  • BSc in Biochemistry and Molecular biology, Benedictine University
  • MSc in Pharmaceutical and Biotechnological Industry, Universitat Pompeu Fabra
  • MBA in Business Administration and Management, ThePowerMBA
Erik Oliemuller García, PhD
Content Contributor
  • Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2021-present)
  • 10+ years experience in clinical and translational research in oncology at international academic institutes
  • PhD in Cellular and Molecular Biology, Universidad de Navarra
  • BSc in Biochemistry, Universidad de Navarra
  • BSc in Biology, Universidad de Navarra
Dale Friel
Content Contributor
  • Senior Analyst at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • Research assistant – Metabolomics lab at NUI Galway, Ireland
  • BS Biomedical Science (Physiology) from the National University of Ireland, Galway
Dafni Chondronasiou, PhD​
Content Contributor
  • Associate Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • 10+ years experience in basic and translational oncology and cellular plasticity in international academic institutes
  • PhD in Biosciences, Autonomous University of Madrid, Spain
  • MSc in Biomedical Sciences, University of Amsterdam, the Netherlands
  • BSc in Biology, Aristotle University of Thessaloniki, Greece (+6 months in University of Rennes 1, France)

MEET THE ‘TELLIGENCE IN OUR TEAM

Matthew Maryniak
Team Lead
  • Co-founder & President of Fenix Group International, LLC, a global life sciences consulting firm parent company of Celltelligence (2015-present)
  • Former Principal at IQVIA Consulting Group (8 years tenure)
  • Recognized industry expert in Pink Sheet, PM360, and journal article
  • MBA in Pharmaceutical Business, Univ of Sciences in PHL
Antonio Marti Polo, MSc
Senior Content Lead
  • Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2020-present)
  • BSc in Biochemistry and Molecular biology, Benedictine University
  • MSc in Pharmaceutical and Biotechnological Industry, Universitat Pompeu Fabra
  • MBA in Business Administration and Management, ThePowerMBA
Erik Oliemuller García, PhD
Content Contributor
  • Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2021-present)
  • 10+ years experience in clinical and translational research in oncology at international academic institutes
  • PhD in Cellular and Molecular Biology, Universidad de Navarra
  • BSc in Biochemistry, Universidad de Navarra
  • BSc in Biology, Universidad de Navarra
Dale Friel
Content Contributor
  • Senior Analyst at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • Research assistant – Metabolomics lab at NUI Galway, Ireland
  • BS Biomedical Science (Physiology) from the National University of Ireland, Galway
Dafni Chondronasiou, PhD
Content Contributor
  • Associate Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • 10+ years experience in basic and translational oncology and cellular plasticity in international academic institutes
  • PhD in Biosciences, Autonomous University of Madrid, Spain
  • MSc in Biomedical Sciences, University of Amsterdam, the Netherlands
  • BSc in Biology, Aristotle University of Thessaloniki, Greece (+6 months in University of Rennes 1, France)

START TODAY FOR FREE

Get contextualized, actionable insights on the cell therapy landscape and all its players delivered to your inbox weekly.

SIGN UP FREE

Copyright © 2022 Fenix Group International, LLC